Evidence map›Paper›PMID 26537681›Full record

ArticleJournal of virology2016

Correlation between Virus Replication and Antibody Responses in Macaques following Infection with Pandemic Influenza A Virus.

Gerrit Koopman, Petra Mooij, Liesbeth Dekking, Daniëlla Mortier, Ivonne G Nieuwenhuis, Melanie van Heteren, Harmjan Kuipers, Edmond J Remarque, Katarina Radošević, Willy M J M Bogers

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Gerrit KoopmanDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Petra MooijDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands mooij@bprc.nl.
Liesbeth DekkingCrucell Holland B.V., Janssen Pharmaceutical Companies of Johnson & Johnson, Leiden, The Netherlands.
Daniëlla MortierDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Ivonne G NieuwenhuisDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Melanie van HeterenDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Harmjan KuipersCrucell Holland B.V., Janssen Pharmaceutical Companies of Johnson & Johnson, Leiden, The Netherlands.
Edmond J RemarqueDepartment of Parasitology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Katarina RadoševićCrucell Holland B.V., Janssen Pharmaceutical Companies of Johnson & Johnson, Leiden, The Netherlands.
Willy M J M BogersDepartment of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Biomedical Primate Research Centre · NLJohnson & Johnson (Netherlands) · NLJanssen (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledInfluenza virus infection of nonhuman primates is a well-established animal model for studying pathogenesis and for evaluating prophylactic and therapeutic intervention strategies. However, usually a standard dose is used for the infection, and there is no information on the relation between challenge dose and virus replication or the induction of immune responses. Such information is also very scarce for humans and largely confined to evaluation of attenuated virus strains. Here, we have compared the effect of a commonly used dose (4 × 10(6) 50% tissue culture infective doses) versus a 100-fold-higher dose, administered by intrabronchial installation, to two groups of 6 cynomolgus macaques. Animals infected with the high virus dose showed more fever and had higher peak levels of gamma interferon in the blood. However, virus replication in the trachea was not significantly different between the groups, although in 2 out of 6 animals from the high-dose group it was present at higher levels and for a longer duration. The virus-specific antibody response was not significantly different between the groups. However, antibody enzyme-linked immunosorbent assay, virus neutralization, and hemagglutination inhibition antibody titers correlated with cumulative virus production in the trachea. In conclusion, using influenza virus infection in cynomolgus macaques as a model, we demonstrated a relationship between the level of virus production upon infection and induction of functional antibody responses against the virus. IMPORTANCE: There is only very limited information on the effect of virus inoculation dose on the level of virus production and the induction of adaptive immune responses in humans or nonhuman primates. We found only a marginal and variable effect of virus dose on virus production in the trachea but a significant effect on body temperature. The induction of functional antibody responses, including virus neutralization titer, hemagglutination inhibition titer, and antibody-dependent cell-mediated cytotoxicity, correlated with the level of virus replication measured in the trachea. The study reveals a relationship between virus production and functional antibody formation, which could be relevant in defining appropriate criteria for new influenza virus vaccine candidates.

Indexed as

Antibody FormationVirus ReplicationAnimalsAntibodies, NeutralizingAntibodies, ViralDose-Response Relationship, ImmunologicEnzyme-Linked Immunosorbent AssayHemagglutination Inhibition TestsInfluenza A Virus, H1N1 SubtypeMacaca fascicularisMaleNeutralization TestsTracheaViral LoadAntibodies, NeutralizingAntibodies, Viral

Identifiers

PMID26537681
PMCPMC4702706
OpenAlexW2189914655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.